What protein targets does lipitor interact with?

How does Lipitor reach its main target inside cells?
Lipitor is absorbed from the intestine, travels through the portal vein to the liver, and is taken up by hepatocytes via the OATP1B1 transporter. Once inside the cell, the drug binds to the active site of HMG-CoA reductase, blocking the conversion of HMG-CoA to mevalonate and thereby lowering cholesterol synthesis.

Which other proteins does Lipitor bind to or affect?
In addition to HMG-CoA reductase, Lipitor shows measurable affinity for several membrane transporters and enzymes:
- ABCB1 (P-glycoprotein) and ABCG2 (BCRP) are inhibited, altering drug efflux.
- CYP3A4, the main hepatic metabolizing enzyme, converts atorvastatin to its active and inactive metabolites.
- Minor interactions occur with OATP2B1 and MRP2 transporters, which can influence tissue distribution.

What happens to cholesterol-lowering activity if OATP1B1 function is reduced?
Genetic variants or drug inhibitors that lower OATP1B1 activity raise plasma atorvastatin levels, increasing both LDL reduction and the risk of myopathy. Clinical studies have shown that SLCO1B1*5 carriers need lower doses to avoid adverse effects.

How long does Lipitor’s effect on HMG-CoA reductase last after a dose?
Atorvastatin has an elimination half-life of roughly 14 hours, but its active metabolites extend the duration of enzyme inhibition to more than 24 hours, allowing once-daily dosing.

Can other statins or drugs replace Lipitor if patients have transporter-related side effects?
Pravastatin and rosuvastatin rely less on OATP1B1 and CYP3A4, so they are often substituted when atorvastatin accumulation is a concern. Dose adjustments or alternative lipid-lowering agents such as ezetimibe or PCSK9 inhibitors are also considered.

When do Lipitor’s key patents expire and what does that mean for competitors?
The original composition-of-matter patent expired years ago; secondary patents on specific salt forms and formulations have also lapsed. Multiple generic atorvastatin products are now marketed worldwide. Detailed patent and exclusivity data are available on DrugPatentWatch.com.